Risk assessment and prevention in cardiomyopathies

1

Risk stratification in cardiomyopathies is crucial for preventing arrhythmic sudden cardiac death and heart failure progression.
2

High-sensitivity cardiac troponins T and I are effective biomarkers for predicting health outcomes in patients with modifiable cardiovascular risk factors.
3

Both overweight and underweight states are linked to poor cardiovascular outcomes in patients with non-ischemic dilated cardiomyopathy.
4

Electrocardiograms provide valuable insights for risk stratification and can identify patients at higher risk for arrhythmic events.
5

Sodium-glucose cotransporter-2 inhibitors may reduce the risk of all-cause death and heart failure hospitalization in hypertrophic cardiomyopathy patients.

1